Ticker Details
Sarepta Therapeutics, Inc. Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
IPO Date:	July 12, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.17B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.76 | 2.95%
Avg Daily Range (30 D):	$0.49 | 2.90%
Avg Daily Range (90 D):	$0.54 | 2.90%

Institutional Daily Volume
Avg Daily Volume:	1.86M
Avg Daily Volume (30 D):	2.66M
Avg Daily Volume (90 D):	2.59M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	72

Institutional Trades
Total Institutional Trades:	14,098
Avg Institutional Trade:	$4.06M
Avg Institutional Trade (30 D):	$6.37M
Avg Institutional Trade (90 D):	$4.62M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$8.77M
Avg Closing Trade (30 D):	$12.17M
Avg Closing Trade (90 D):	$8.86M
Avg Closing Volume:	135.08K

News

May 20, 2026 @ 3:15 PM My Top 3 Biotech Stocks for May 2026 Source: Jeff Siegel

May 18, 2026 @ 6:33 PM Protein Synthesis Research Market to Reach $42.8 B... Source: Bcc Research

Mar 27, 2026 @ 5:09 PM Nasdaq 100 Enters Correction As 30-Year Yields Nea... Source: Piero Cingari

Jan 26, 2026 @ 1:41 PM Stock Market Today: Dow Futures Gain, S&P 500 Slip... Source: Rishabh Mishra

Jan 22, 2026 @ 3:30 AM 2 Beaten-Down Stocks That Could Sink Even More in ... Source: Prosper Junior Bakiny

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.15	$-3.93	$-7.13
Diluted EPS	$2.88	$-3.93	$-7.13
Revenue	$730.8M	$442.93M	$2.2B
Gross Profit		$-29.1M	$2.17B
Net Income / Loss	$330.96M	$-412.23M	$-713.41M
Operating Income / Loss	$358.43M	$-411.58M	$-699.78M
Cost of Revenue		$472.04M	$25.5M
Net Cash Flow	$-336.83M	$188.21M	$-304.18M
PE Ratio

Splits
Jul 12, 2012	1:6